Statistics

UNODC Current NPS Threats

Report
 - 
The UNODC Early Warning Advisory highlights a continued global expansion of new psychoactive substances (NPS), with nearly 1,400 substances reported worldwide. In 2024 alone, a record number of substances were identified, including over 100...
UNOPS

Stimulant Use and Related Harms in Canada: Recent Trends

Report
 - 
This report highlights a growing concern around stimulant use and related harms in Canada, particularly involving cocaine and methamphetamine. Data from multiple national sources show that stimulant-related deaths have significantly...
CCSA

Instrument for Pre-accession Assistance (IPA) data sheets

Leaflet, Infographic, Fact sheet, Poster
 - 
The European Union Drugs Agency has released updated data sheets providing a clear and comparable overview of drug-related indicators across six Western Balkan partners under the Instrument for Pre-accession Assistance (IPA). These include...
EUDA Data Sheet

Conceptualising drug market-related violence

Event Date
 - 
Online

Date: 16 June 2026, 14:30–16:00 Lisbon time (WEST) — 15:30–17:00 (CEST).

Objective: This webinar seeks to inform participants on the concept of drug market-related violence, how to conceptualise it and how to measure it.

Ketamine in Europe

Event Date
 - 
Online

ObjectiveThis webinar aims to provide insights into the European ketamine market and will expand on health-related harms caused by non-medical ketamine use.

Launch event: European Drug Report 2026

Event Date
 - 
Online

Join us for the launch of the European Drug Report 2026: Trends and Developments on 9 June 2026. The report delivers the latest evidence on the state of the drugs problem in Europe.

Time: 09:00 WEST (Lisbon), 10:00 CEST (Brussels) (NB time to be confirmed)

EUDA webinar: International drug checking day

Event Date
 - 
Online

Objective: Taking place on the eve of International Drug Checking Day, this webinar offers a timely opportunity to highlight the role drug-checking services play across three domains: harm reduction, drug market monitoring and public health alerts. The session will demonstrate the benefits of drug checking for a variety of stakeholders, including consumers, public health authorities and monitoring bodies.